Regeneron Pharmaceuticals, Inc.
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor

Abstract:

The present invention provides methods for treating, preventing or reducing the severity of eosinophilic esophagitis. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R.alpha.) inhibitor such as an anti-IL-4R.alpha. antibody.